Australia’s S&P/ASX 200 (Index: ^AXJO)(ASX: XJO) and ALL ORDINARIES (Index: ^AXAO) (ASX: XAO) indices finished lower on Thursday.
Here’s a short recap of the Australian market:
- S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) lower 0.79% to 6.669.30
- ALL ORDINARIES (Index: ^AXAO) (ASX: XAO) lower 0.80% to 6,774.50
- AUD/USD at US 68 cents
- Gold at US$1,471.42 an ounce
- Brent Oil at US$62.19 a barrel
One of the best-performing ASX 200 shares today was the Monadelphous Group Limited (ASX: MND) share price which grew 3.1% after yesterday’s contract win.
The IPH Ltd (ASX: IPH) share price fell almost 5% today after holding its AGM.
Westpac Banking Corp (ASX: WBC) saw its share price fall another 2% after the AUSTRAC allegations.
The share price of National Australia Bank Ltd (ASX: NAB) fell 0.5% after settling a class action and announcing the cost to the market.
The Noni B Limited (ASX: NBL) share price dropped 2.75% after announcing an acquisition and holding its AGM.
Penthrox business Medical Developments International Ltd (ASX: MVP) announced an exciting piece of China-related news, sending the share price up 5%.
The share price of Think Childcare Ltd (ASX: TNK) rose 5.3% after the company gave a trading update.
Finally, the share price of A2B Australia Ltd (ASX: A2B) fell 2.4% after it held its AGM today.
Here are some of today’s top stories:
- Will iSignthis’s ESG certificate impress the ASX?
- Are baby boomers responsible for low interest rates?
- How to live off dividends and never work again
- I went to the A2 Milk company AGM. Here’s what I learned
The post ALL ORDINARIES finishes lower Thursday: 8 ASX shares you missed appeared first on Motley Fool Australia.
The Fool investment team has identified these ASX shares that could be worth a place in your portfolio.
You’re invited! For a limited time, The Motley Fool Australia is giving away an urgent new investment report detailing our 3 TOP BLUE CHIP SHARES to own in 2019.
So if you like trustworthy, stable, high-performing companies that pay fat fully franked dividends – we’ve got you covered!
Stock #1 is a beloved old Australian company turning its attention to high-margin businesses... and rapidly returning cash to shareholders with its hefty dividend...
While Stock #2 is an online powerhouse that’s rapidly gaining market share all around the globe... poised for years (or even decades) of tremendous growth...
Even better, Stock #3 offers a whopping 6.5% grossed-up dividend! Which beats the rates on term deposits right out of the water – and offers the potential for capital gains, too.
You can discover all three shares inside our new report right now. To scoop up your FREE copy, simply click the link below right now. But you will want to hurry – this free report is available for a LIMITED TIME ONLY!
- Man bets $221,666 on one ASX stock
- Top analysts name their top 3 ASX blue chip shares for 2019
- 3 quality dividend shares to boost your income
- NEW: Free report names top 3 ASX dividend shares to buy for 2019
- 5 Stocks for Potentially Building Wealth After 50
Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of Medical Developments International Limited. The Motley Fool Australia owns shares of National Australia Bank Limited. The Motley Fool Australia has recommended Medical Developments International Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
The Motley Fool's purpose is to help the world invest, better. Click here now for your free subscription to Take Stock, The Motley Fool's free investing newsletter. Packed with stock ideas and investing advice, it is essential reading for anyone looking to build and grow their wealth in the years ahead. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson. 2019